News
The injectable production specialist has snapped up a 65-acre property with more than 300,000 square feet of usable space to ...
Stockhead on MSN1h
Dr Boreham’s Crucible: Oncology-focused Qbiotics hopes to crawl through IPO ‘window of opportunity’
With Virgin shares holding nicely at cruising altitude, is now the right time for private oncology drug developer Qbiotics to ...
Zacks.com on MSN8h
Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?
Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback